Skip to main content
. 2022 Apr 26;14(5):938. doi: 10.3390/pharmaceutics14050938

Figure 5.

Figure 5

Invasion assay after treatment with control (a), AMO solution (at concentrations equivalent to that used for the nanoemulsions) (b), AMO:OLO 80:20 nanoemulsion at an IC60 concentration (c), 30 µg/mL of 5-FU (d), and the calculated percentage of proportional invasiveness for each treatment (e). The values are expressed as mean ± SD (n = 3).